Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Preliminary results
Inv. presentation
Quarterly results
Director departure
|
|
Acutus Medical, Inc. (AFIB)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/07/2023 |
4
| Sohn Tom (SVP, Gen. Counsel & Secretary) has filed a Form 4 on Acutus Medical, Inc.|
Txns:
| Paid exercise price by delivering 433 shares
@ $0.69, valued at
$298.8 |
|
| 08/07/2023 |
4
| Mathews Kevin (SVP, Commercial) has filed a Form 4 on Acutus Medical, Inc.|
Txns:
| Paid exercise price by delivering 134 shares
@ $0.69, valued at
$92.5 |
|
| 08/02/2023 |
4
| Sohn Tom (SVP, Gen. Counsel & Secretary) has filed a Form 4 on Acutus Medical, Inc.|
Txns:
| Granted 20,000 shares
@ $0 |
|
| 08/02/2023 |
4
| Roman David (President & CEO) has filed a Form 4 on Acutus Medical, Inc.|
Txns:
| Paid exercise price by delivering 6,484 shares
@ $0 |
|
| 08/02/2023 |
4
| Mukai Takeo (CFO) has filed a Form 4 on Acutus Medical, Inc.|
Txns:
| Paid exercise price by delivering 501 shares
@ $0 |
|
| 06/15/2023 |
4
| Marzouk Shaden (Director) has filed a Form 4 on Acutus Medical, Inc.|
Txns:
| Granted 8,400 shares
@ $0
Granted 19,600 options to buy
@ $0.8349, valued at
$16.4k
|
|
| 06/15/2023 |
4
| Sheridan John F (Director) has filed a Form 4 on Acutus Medical, Inc.|
Txns:
| Granted 8,400 shares
@ $0
Granted 19,600 options to buy
@ $0.8349, valued at
$16.4k
|
|
| 06/15/2023 |
4
| Bonita David P (Director) has filed a Form 4 on Acutus Medical, Inc.|
Txns:
| Granted 8,400 shares
@ $0
Granted 19,600 options to buy
@ $0.8349, valued at
$16.4k
|
|
| 06/15/2023 |
4
| Huennekens R Scott (Director) has filed a Form 4 on Acutus Medical, Inc.|
Txns:
| Granted 10,920 shares
@ $0
Granted 25,480 options to buy
@ $0.8349, valued at
$21.3k
|
|
| 06/15/2023 |
4
| ElBardissi Andrew (Director) has filed a Form 4 on Acutus Medical, Inc.|
Txns:
| Granted 8,400 shares
@ $0
Granted 19,600 options to buy
@ $0.8349, valued at
$16.4k
|
|
| 06/15/2023 |
4
| Garland Jason K (Director) has filed a Form 4 on Acutus Medical, Inc.|
Txns:
| Granted 8,400 shares
@ $0
Granted 19,600 options to buy
@ $0.8349, valued at
$16.4k
|
|
| 06/15/2023 |
4
| Pellegrini Niamh Louise (Director) has filed a Form 4 on Acutus Medical, Inc.|
Txns:
| Granted 8,400 shares
@ $0
Granted 19,600 options to buy
@ $0.8349, valued at
$16.4k
|
|
| 06/01/2023 |
4
| Roman David (President & CEO) has filed a Form 4 on Acutus Medical, Inc.|
Txns:
| Paid exercise price by delivering 17,290 shares
@ $0.8479, valued at
$14.7k
|
|
| 04/04/2023 |
4
| Mathews Kevin (SVP, Commercial) has filed a Form 4 on Acutus Medical, Inc.|
Txns:
| Paid exercise price by delivering 321 shares
@ $0.754, valued at
$242 |
|
| 04/04/2023 |
4
| Roman David (President & CEO) has filed a Form 4 on Acutus Medical, Inc.|
Txns:
| Paid exercise price by delivering 3,165 shares
@ $0.754, valued at
$2.4k
|
|
| 04/04/2023 |
4
| Piscitello Charlie (SVP, Chief People Officer) has filed a Form 4 on Acutus Medical, Inc.|
Txns:
| Paid exercise price by delivering 855 shares
@ $0.754, valued at
$644.7 |
|
| 04/04/2023 |
4
| Sohn Tom (SVP, Gen. Counsel & Secretary) has filed a Form 4 on Acutus Medical, Inc.|
Txns:
| Paid exercise price by delivering 855 shares
@ $0.754, valued at
$644.7 |
|
| 03/02/2023 |
4
| Sohn Tom (SVP, Gen. Counsel & Secretary) has filed a Form 4 on Acutus Medical, Inc.|
Txns:
| Granted 42,500 shares
@ $0
Granted 42,500 options to buy
@ $1.41, valued at
$59.9k
|
|
| 03/02/2023 |
4
| Mathews Kevin (SVP, Commercial) has filed a Form 4 on Acutus Medical, Inc.|
Txns:
| Granted 42,500 shares
@ $0
Granted 42,500 options to buy
@ $1.41, valued at
$59.9k
|
|
| 03/02/2023 |
4
| Roman David (President & CEO) has filed a Form 4 on Acutus Medical, Inc.|
Txns:
| Granted 135,000 shares
@ $0
Granted 135,000 options to buy
@ $1.41, valued at
$190.4k
|
|
| 03/02/2023 |
4
| Mukai Takeo (CFO) has filed a Form 4 on Acutus Medical, Inc.|
Txns:
| Granted 47,500 shares
@ $0
Granted 47,500 options to buy
@ $1.41, valued at
$67k
|
|
| 03/02/2023 |
4
| Piscitello Charlie (SVP, Chief People Officer) has filed a Form 4 on Acutus Medical, Inc.|
Txns:
| Granted 42,500 shares
@ $0
Granted 42,500 options to buy
@ $1.41, valued at
$59.9k
|
|
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2023 |
4
| Roman David (President & CEO) has filed a Form 4 on Acutus Medical, Inc.|
Txns:
| Paid exercise price by delivering 10,196 shares
@ $1.87, valued at
$19.1k
|
|
| 02/02/2023 |
4
| Piscitello Charlie (SVP, Chief People Officer) has filed a Form 4 on Acutus Medical, Inc.|
Txns:
| Paid exercise price by delivering 6,627 shares
@ $1.87, valued at
$12.4k
|
|
| 02/02/2023 |
4
| Mathews Kevin (SVP, Commercial) has filed a Form 4 on Acutus Medical, Inc.|
Txns:
| Paid exercise price by delivering 3,540 shares
@ $1.87, valued at
$6.6k
|
|
| 02/02/2023 |
4
| Sohn Tom (SVP, Gen. Counsel & Secretary) has filed a Form 4 on Acutus Medical, Inc.|
Txns:
| Paid exercise price by delivering 6,525 shares
@ $1.87, valued at
$12.2k
|
|
| 10/11/2022 |
4
| Huennekens R Scott (Director) has filed a Form 4 on Acutus Medical, Inc.|
Txns:
| Granted 2,520 shares
@ $0
Granted 5,880 options to buy
@ $0.88, valued at
$5.2k
|
|
| 09/02/2022 |
4
| Garland Jason K (Director) has filed a Form 4 on Acutus Medical, Inc.|
Txns:
| Granted 14,000 shares
@ $0
Granted 32,500 options to buy
@ $1.13, valued at
$36.7k
|
|
| 09/02/2022 |
4
| Mukai Takeo (Interim CFO) has filed a Form 4 on Acutus Medical, Inc.|
Txns:
| Granted 20,000 shares
@ $0 |
|
| 08/01/2022 |
4
| Roman David (President & CEO) has filed a Form 4 on Acutus Medical, Inc.|
Txns:
| Granted 75,000 shares
@ $0
Disposed/sold 77,335 options to buy
@ $13.66, valued at
$1.1M
Granted 77,335 options to buy
@ $1.34, valued at
$103.6k
Disposed/sold 50,000 options to buy
@ $2.41, valued at
$120.5k
Granted 50,000 options to buy
@ $1.34, valued at
$67k
|
|
| 08/01/2022 |
4
| Sohn Tom (SVP, Gen. Counsel & Secretary) has filed a Form 4 on Acutus Medical, Inc.|
Txns:
| Disposed/sold 41,134 options to buy
@ $14.81, valued at
$609.2k
Granted 41,134 options to buy
@ $1.34, valued at
$55.1k
Disposed/sold 28,022 options to buy
@ $18, valued at
$504.4k
Granted 28,022 options to buy
@ $1.34, valued at
$37.5k
Disposed/sold 34,800 options to buy
@ $13.66, valued at
$475.4k
Granted 34,800 options to buy
@ $1.34, valued at
$46.6k
Disposed/sold 32,000 options to buy
@ $2.41, valued at
$77.1k
Granted 32,000 options to buy
@ $1.34, valued at
$42.9k
|
|
| 08/01/2022 |
4
| Mathews Kevin (SVP, Global Sales) has filed a Form 4 on Acutus Medical, Inc.|
Txns:
| Disposed/sold 21,583 options to buy
@ $18, valued at
$388.5k
Granted 21,583 options to buy
@ $1.34, valued at
$28.9k
Disposed/sold 15,467 options to buy
@ $13.66, valued at
$211.3k
Granted 15,647 options to buy
@ $1.34, valued at
$21k
Disposed/sold 20,000 options to buy
@ $2.41, valued at
$48.2k
Granted 20,000 options to buy
@ $1.34, valued at
$26.8k
|
|
| 08/01/2022 |
4
| Piscitello Charlie (Chief People Officer) has filed a Form 4 on Acutus Medical, Inc.|
Txns:
| Disposed/sold 51,418 options to buy
@ $13.38, valued at
$688k
Granted 51,418 options to buy
@ $1.34, valued at
$68.9k
Disposed/sold 28,022 options to buy
@ $18, valued at
$504.4k
Granted 28,022 options to buy
@ $1.34, valued at
$37.5k
Disposed/sold 34,800 options to buy
@ $13.66, valued at
$475.4k
Granted 34,800 options to buy
@ $1.34, valued at
$46.6k
Disposed/sold 32,500 options to buy
@ $2.41, valued at
$78.3k
Granted 32,500 options to buy
@ $1.34, valued at
$43.6k
|
|
|
|
|